Articles & Issues

Alert me when new Articles in Press are available. Add Articles in Press Alert or RSS Feed

9 Articles

Article Title	Author(s)	Type (Status)	Available Online
Thoracic Radiotherapy for Limited Stage Small Cell Lung Carcinoma DOI: 10.1016/j.currproblcancer.2012.03.001 Preview Full Text PDF (437 KB) Lung cancer remains the most common cause of cancer death in the United States. Small cell lung carcinoma (SCLC) compromises approximately 13% of lung cancer diagnoses, a decline from approximately 17...	Paul D. Aridgides, Benjamin Movsas, Jeffrey A. Bogart	Full-length article (*In Press Corrected Proof*)	12 April 2012
Role of Surgery for Small Cell Lung Cancer DOI: 10.1016/j.currproblcancer.2012.03.003 Preview Full Text PDF (300 KB) The body of literature investigating the rational for surgery as an integral part of the treatment of small cell lung cancer (SCLC) centers around one main question “Is there a benefit?” The supportin...	Vincent E. Lotano, Joe Friedberg	Full-length article (*In Press Corrected Proof*)	12 April 2012
Using the Surveillance, Epidemiology, and End Results Database to Investigate Rare Cancers, Second Malignancies, and Trends in Epidemiology, Treatment, and Outcomes DOI: 10.1016/j.currproblcancer.2012.03.008 Preview Full Text PDF (179 KB) The study of rare cancers has been a particularly active area of investigation with Surveillance, Epidemiology, and End Results (SEER) Program data. Although the definition of a rare cancer can be des...	Shane Lloyd, Henry S. Park, Roy H. Decker, Lynn D. Wilson, James B. Yu et al.	Full-length article (*In Press Corrected Proof*)	12 April 2012
Novel Therapeutic Approaches for Small Cell Lung Cancer: The Future has Arrived DOI: 10.1016/j.currproblcancer.2012.03.005 Preview Full Text PDF (437 KB) Thirty thousand patients are diagnosed with small cell lung cancer (SCLC) in the United States each year. Tobacco exposure is strongly associated with the development of this disease. SCLC has a uniqu...	M. Catherine Pietanza, Charles M. Rudin	Full-length article (*In Press Corrected Proof*)	12 April 2012
Overview of the Surveillance, Epidemiology, and End Results Database: Evolution, Data Variables, and Quality Assurance DOI: 10.1016/j.currproblcancer.2012.03.007 Preview Full Text PDF (487 KB) The Surveillance, Epidemiology, and End Results (SEER) program of the National Cancer Institute (NCI) is a widely used and comprehensive source of cancer incidence, staging, treatment, and survival in...	Henry S. Park, Shane Lloyd, Roy H. Decker, Lynn D. Wilson, James B. Yu et al.	Full-length article (*In Press Corrected Proof*)	05 April 2012
Prophylactic Cranial Irradiation: Do Benefits Outweigh Neurocognitive Impact? DOI: 10.1016/j.currproblcancer.2012.03.002 Preview Full Text PDF (222 KB) Small cell lung cancer is a clinically aggressive entity, with a high propensity for spread to the central nervous system. Therapy for both local and systemic diseases has improved during the past sev...	Jean Wright, Aaron Wolfson	Full-length article (*In Press Corrected Proof*)	05 April 2012
Prediction Models, Nomograms, and Staging Validation with the Surveillance, Epidemiology, and End Results Database DOI: 10.1016/j.currproblcancer.2012.03.009 Preview Full Text PDF (157 KB) Many clinical researchers have devised prognostic models using the demographic and clinicopathologic variables included in SEER. The large number of patients available from the SEER database endows ro...	Shane Lloyd, Henry S. Park, Lynn D. Wilson, Roy H. Decker, James B. Yu et al.	Full-length article (*In Press Corrected Proof*)	05 April 2012
Comparative Effectiveness Research and the Surveillance, Epidemiology, and End Results Database DOI: 10.1016/j.currproblcancer.2012.03.010 Preview Full Text PDF (248 KB) The Institute of Medicine has defined CER as “the generation and synthesis of evidence that compares the benefits and harms of alternative methods to prevent, diagnose, treat, and monitor a clinical c...	James B. Yu, Shane Lloyd, Roy H. Decker, Lynn D. Wilson, Henry S. Park et al.	Full-length article (*In Press Corrected Proof*)	05 April 2012
Limitations and Biases of the Surveillance, Epidemiology, and End Results Database DOI: 10.1016/j.currproblcancer.2012.03.011 Preview Full Text PDF (554 KB) Although the Surveillance, Epidemiology, and End Results (SEER) database is an extremely valuable tool for clinical cancer research, several limitations should be taken into account when interpreting ...	Henry S. Park, Shane Lloyd, Roy H. Decker, Lynn D. Wilson, James B. Yu et al.	Full-length article (*In Press Corrected Proof*)	05 April 2012

Note to users: The section "Articles in Press" contains peer reviewed and accepted articles to be published in this journal. When the final article is assigned to an issue of the journal, the "Article in Press" version will be removed from this section and will appear in the associated journal issue. Please be aware that "Articles in Press" do not have all bibliographic details available yet. There are three types of "Articles in Press":

Accepted Manuscripts: these are manuscripts that have been selected for publication. They have not been typeset and the text may change before final publication.
Uncorrected proofs: these are articles that are not yet finalized and that will be corrected by the authors. Therefore the text could change before final publication. Uncorrected proofs may be temporarily unavailable for production reasons.
Corrected proofs: these are articles containing the authors' corrections. The content of the article will usually remain unchanged, and possible further corrections are fairly minor. Typically the only difference with the finally published article is that specific issue and page numbers have not yet been assigned.